Eurogin is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Save the date and join us for another remarkable event as we continue to advance the field of HPV research and cancer prevention.
Early bird rates ends on February 12, 2024.
Secure your pass now.
EUROGIN is the world's leading international congress on HPV infections and associated cancers with a focus on prevention and diagnostics.
The event aims at translating scientific and evidence-based research into clinical practice through its high-quality and innovative program drawn up by outstanding international leaders. The conference offers a forum to exchange knowledge and experience with peers from all over the world.
Explore our program topics to get a glimpse of what awaits you in Stockholm. From cutting-edge research and its clinical applications, to in-depth discussions on the latest advancements in HPV-associated diseases, EUROGIN 2024 promises to be a dynamic and informative experience.
France
Netherlands
Sweden
PARTICIPANTS
COUNTRIES
SPEAKERS & POSTER PRESENTERS
ORAL PRESENTATIONS
Everything was great and very well organised.
The sessions were excellent. The data presented were often new and integrated with what was known previously – very helpful.
I most appreciated the quality of the presentations, mix of speakers - scientists, epidemiologists, program managers, academics etc.
EUROGIN offers the opportunity of networking with colleagues from all over the world.
Be the first to receive updates on our upcoming program and workshops, speakers, special rates and more! Let’s stay in touch!
We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy and Cookie Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.